Enzymatic assay for measurement of intracellular DXG triphosphate concentrations in peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected patients

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 1, 2003, Pages 255-261

  Kewn, Stephen ^a   Wang, Laurene H ^b   Hoggard, Patrick G ^a   Rousseau, Franck ^b   Hart, Robert ^b   MacNeela, John P ^b   Khoo, Saye H ^a   Back, David J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1,9 DIHYDRO 9 [2 [HYDROXYMETHYL] 1,3 DIOXOLAN 4 YL] 6H PURIN 6 ONE; 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; AMDOXOVIR; DEOXYGUANOSINE TRIPHOSPHATE; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; ENZYME ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; PRIORITY JOURNAL;

DIOXOLANES; GUANOSINE; HIV INFECTIONS; HIV-1; HUMANS; PURINE NUCLEOSIDES;

EID: 12244301646     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.1.255-261.2003     Document Type: Article

References (23)

1. Barry, M. G., M. Wild, G. J. Veal, D. J. Back, A. M. Breckenridge, R. M. Fox, N. J. Beeching, F. J. Nye, P. Carey, and D. Timmins. 1994. Zidovudine phosphorylation in HIV-infected patients and seronegative volunteers. AIDS 8:F1-F5.
2. Barry, M. G., S. H. Khoo, G. J. Veal, P. G. Hoggard, S. E. Gibbons, E. G. L. Wilkins, O. Williams, A. M. Breckenridge, and D. J. Back. 1996. The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites. AIDS 10:1361-1367.
3. Bazmi, H. Z., J. L. Hammond, S. C. H. Cavalcanti, C. K. Chu, R. F. Schinazi, and J. W. Mellors. 2000. In vitro selection of mutations in human immunodeficiency virus type 1 reverse transcriptase that decrease susceptibility to (-)-β-D-dioxolane-guanosine and suppress resistance to 3′-azido-3′-deoxythymidine. Antimicrob. Agents Chemother. 44:1783-1788.
4. Chen, H., F. D. Boudinot, C. K. Chu, H. M. McClure, and R. F. Schinazi. 1996. Pharmacokinetics of (-)-β-D-2-aminopurine dioxolane and (-)-β-D-2-amino-6-chloropurine dioxolane and their antiviral metabolite (-)-β-D-2,6-dioxolane guanine in rhesus monkeys. Antimicrob. Agents Chemother. 40:2332-2336.
5. Chen, H., R. F. Schinazi, P. Rajagopalan, Z. Gao, C. K. Chu, H. M. McClure, and F. D. Boudinot. 1999. Pharmacokinetics of (-)-β-D-dioxolane guanine and prodrug (-)-β-D-diaminopurine dioxolane in rats and monkeys. AIDS Res. Hum. Retrovir. 15:1623-1630.
6. Collier, A. C., S. Bozzette, R. W. Coombs, D. M. Causey, D. A. Schoenfeld, S. A. Spector, C. B. Pettinelli, G. Davis, D. D. Richman, J. M. Leedom, P. Kidd, and L. Corey. 1990. A pilot study of low-dose zidovudine in human immunodeficiency virus infection. N. Engl. J. Med. 323:1015-1021.
7. Furman, P. A., J. A. Fyfe, M. H. St. Clair, K. Weinhold, J. L. Rideout, G. A. Freeman, S. N. Lehrman, D. P. Bolognesi, S. Broder, H. Mitsuya, and D. W. Barry. 1986. Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc. Natl. Acad. Sci. USA 83:8333-8337.
8. Furman, P. A., J. Jeffrey, L. L. Kiefer, J. Y. Feng, K. S. Anderson, K. Borroto-Esoda, E. Hill, W. C. Copeland, C. K. Chu, J.-P. Sommadossi, I. Liberman, R. F. Schinazi, and G. R. Painter. 2001. Mechanism of action of 1-β-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-β-D-dioxolane guanosine. Antimicrob. Agents Chemother. 45:158-165.
9. Gu, Z., M. A. Wainberg, N. Nguyen-Ba, L. L'Heureux, J.-M. de Muys, T. L. Bowlin, and R. F. Rando. 1999. Mechanism of action and in vitro activity of 1′,3′-dioxolanylpurine nucleoside analogues against sensitive and drug-resistant human immunodeficiency virus type 1 variants. Antimicrob. Agents Chemother. 43:2376-2392.
10. Hart, G. J., D. C. Orr, C. R. Penn, H. T. Figueiredo, N. M. Gray, R. E. Boehme, and J. M. Cameron. 1992. Effects of (-)-2′-deoxy-3′-thiacytidine (3TC) 5′-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerase alpha, beta, and gamma. Antimicrob. Agents Chemother. 36:1688-1694.
11. Hoggard, P. G., J. Lloyd, S. H. Khoo, M. G. Barry, L. Dann, S. E. Gibbons, E. G. Wilkins, C. Loveday, and D. J. Back. 2001. Zidovudine phosphorylation determined sequentially over 12 months in human immunodeficiency virus-infected patients with or without previous exposure to antiretroviral agents. Antimicrob. Agents Chemother. 45:976-980.
12. Kewn, S., G. J. Veal, P. G. Hoggard, M. G. Barry, and D. J. Back. 1997. Lamivudine (3TC) phosphorylation and drug interactions in vitro. Biochem. Pharmacol. 54:589-595.
13. Kewn, S., P. G. Hoggard, S. D. Sales, K. Jones, B. Maher, S. H. Khoo, and D. J. Back. 2002. Development of enzymatic assays for quantification of intracellular lamivudine and carbovir triphosphate levels in peripheral blood mononuclear cells from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 46:135-143.
14. Kim, H. O., R. F. Schinazi, S. Nampalli, K. Shanmuganathan, D. L. Cannon, A. J. Alves, L. S. Jeong, J. W. Beach, and C. K. Chu. 1993. 1,3-Dioxolanylpurine nucleosides (2R, 4R) and (2R, 4S) with sensitive anti-HIV-1 activity in human lymphocytes. J. Med. Chem. 36:30-37.
15. Mitsuya, H., and S. Broder. 1986. Inhibition of the in vitro activity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides. Proc. Natl. Acad. Sci. USA 83:1911-1915.
16. Moore, J. D., G. Valette, A. Darque, X. J. Zhoo, and J.-P. Sommadossi. 2000. Simultaneous quantitation of the 5′-triphosphate metabolites of zidovudine, lamivudine, and stavudine in peripheral mononuclear blood cells of HIV infected patients by high-performance liquid chromatography tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 11:1134-1143.
17. Moore, K. H., J. E. Barrett, S. Shaw, G. E. Pakes, R. Churchus, A. Kapoor, J. Lloyd, M. G. Barry, and D. J. Back. 1999. The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1. AIDS 13:2239-2250.
18. Rajagopalan, P., F. D. Boudinot, C. K. Chu, B. C. Tennant, B. H. Baldwin, and R. F. Schinazi. 1996. Pharmacokinetics of (-)-β-D-2,6-diaminopurine dioxolane and its metabolite, dioxolane guanosine, in woodchucks (Marmota monax). Antivir. Chem. Chemother. 7:65-70.
19. Robbins, B. L., T. T. Tran, F. H. Pinkerton, Jr., F. Akeb, R. Guedj, J. Grassi, D. Lancaster, and A. Fridland. 1998. Development of a new cartridge radioimmunoassay for determination of intracellular levels of lamivudine triphosphate in the peripheral blood mononuclear cells of human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 42:2656-2660.
20. Rodriguez, J. F., J. L. Rodriguez, J. Santana, H. Garcia, and O. Rosario. 2000. Simultaneous quantitation of intracellular zidovudine and lamivudine triphosphates in human immunodeficiency virus-infected individuals. Antimicrob. Agents Chemother. 44:3097-3100.
21. Sherman, P. A., and J. A. Fyfe. 1989. Enzymatic assay for deoxynucleoside triphosphates using synthetic oligonucleotides as template primers. Anal. Biochem. 180:222-226.
22. Siddiqui, M. A., W. L. Brown, N. Nguyen-Ba, D. M. Dixit, and T. S. Mansour. 1993. Antiviral optically pure dioxolane purine nucleoside analogs. Bioorg. Med. Chem. Lett. 3:1543-1546.
23. Stretcher, B. N., A. J. Pesce, B. A. Geisler, and W. H. Vine. 1991. A coupled HPLC/radioimmunoassay for analysis of zidovudine metabolites in mononuclear cells. Liq. Chromatogr. 14:2261-2272.